Posttransplant administration of donor leukocytes induces long-term acceptance of kidney or liver transplants by an activation-associated immune mechanism

被引:40
作者
Yan, YQ
Shastry, S
Richards, C
Wang, CM
Bowen, DG
Sharland, AF
Painter, DM
McCaughan, GW
Bishop, GA
机构
[1] Royal Prince Alfred Hosp, Centenary Inst Canc Med & Cell Biol, Camperdown, NSW 2050, Australia
[2] Royal Prince Alfred Hosp, Dept Surg, Camperdown, NSW 2050, Australia
[3] Royal Prince Alfred Hosp, Dept Anat Pathol, Camperdown, NSW 2050, Australia
关键词
D O I
10.4049/jimmunol.166.8.5258
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Donor leukocytes play a dual role in rejection and acceptance of transplanted organs. They provide the major stimulus for rejection, and their removal from the transplanted organ prolongs its survival. Paradoxically, administration of donor leukocytes also prolongs allograft survival provided that they are administered 1 wk or more before transplantation. Here we show that administration of donor leukocytes immediately after transplantation induced long-term acceptance of completely MHC-mismatched rat kidney or liver transplants. The majority of long-term recipients of kidney transplants were tolerant of donor-strain skin grafts. Acceptance was associated with early activation of recipient T cells in the spleen, demonstrated by a rapid increase in IL-2 and IFN-gamma at that site followed by an early diffuse infiltrate of activated T cells and apoptosis within the tolerant grafts. In contrast, IL-2 and IFN-gamma mRNA were not increased in the spleens of rejecting animals, and the diffuse infiltrate of activated T cells appeared later but resulted in rapid graft destruction. These results define a mechanism of allograft acceptance induced by donor leukocytes that is associated with activation-induced cell death of recipient T cells. They demonstrate for the first time that posttransplant administration of donor leukocytes leads to organ allograft tolerance across a complete MHC class I plus class II barrier, a finding with direct clinical application.
引用
收藏
页码:5258 / 5264
页数:7
相关论文
共 34 条
[1]  
Bishop GA, 1996, J IMMUNOL, V156, P4925
[2]   SURVIVAL OF UNMODIFIED SPLEEN ALLOGRAFTS IN RATS [J].
BITTERSUERMANN, H .
NATURE, 1974, 247 (5441) :465-466
[3]   DONOR-SPECIFIC TRANSFUSION AND DONOR BONE-MARROW INFUSION IN RENAL-TRANSPLANTATION TOLERANCE - A REVIEW OF EFFICACY AND MECHANISMS [J].
BRENNAN, DC ;
MOHANAKUMAR, T ;
FLYE, MW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (05) :701-715
[4]  
BRENT L, 1962, NATURE, V196, P1208
[5]   ABROGATION OF THE IMMUNOSUPPRESSIVE EFFECT OF DONOR SPLEEN-CELLS ON RENAL-ALLOGRAFTS IN THE RAT BY IRRADIATION OR HEAT-TREATMENT [J].
CRANSTON, D ;
WOOD, KJ ;
MORRIS, PJ .
TRANSPLANTATION, 1986, 42 (03) :302-306
[6]  
Dai ZH, 1998, J IMMUNOL, V161, P1659
[7]   Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection [J].
Ehl, S ;
Aichele, P ;
Ramseier, H ;
Barchet, W ;
Hombach, J ;
Pircher, H ;
Hengartner, H ;
Zinkernagel, RM .
NATURE MEDICINE, 1998, 4 (09) :1015-1019
[8]   Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells [J].
Genestier, L ;
Paillot, R ;
Fournel, S ;
Ferraro, C ;
Miossec, P ;
Revillard, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (02) :322-328
[9]   ACQUIRED TOLERANCE TO HOMOGRAFTS PRODUCED BY HOMOLOGOUS SPLEEN CELL INJECTION IN ADULT MICE [J].
GUTTMANN, RD ;
AUST, JB .
NATURE, 1961, 192 (480) :564-&
[10]   Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates [J].
Kirk, AD ;
Burkly, LC ;
Batty, DS ;
Baumgartner, RE ;
Berning, JD ;
Buchanan, K ;
Fechner, JH ;
Germond, RL ;
Kampen, RL ;
Patterson, NB ;
Swanson, SJ ;
Tadaki, DK ;
TenHoor, CN ;
White, L ;
Knechtle, SJ ;
Harlan, DM .
NATURE MEDICINE, 1999, 5 (06) :686-693